GeneDx Holdings Corp. (WGS)
89.85
-0.82
(-0.90%)
USD |
NASDAQ |
Feb 13, 14:13
GeneDx Holdings Cash from Investing (Quarterly) : -4.687M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Illumina, Inc. | 108.00M |
| Quest Diagnostics, Inc. | -191.00M |
| Labcorp Holdings, Inc. | -374.00M |
| Natera, Inc. | -19.90M |
| Guardant Health, Inc. | -14.35M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 15.77M |
| Cash from Financing (Quarterly) | 10.77M |
| Free Cash Flow | 15.47M |
| Free Cash Flow Per Share (Quarterly) | 0.3332 |
| Free Cash Flow to Equity (Quarterly) | 10.81M |
| Free Cash Flow to Firm (Quarterly) | 10.18M |
| Free Cash Flow Yield | 0.60% |